Sorafenib Inhibits Many Kinase Mutations Associated with Drug-Resistant Gastrointestinal Stromal Tumors

per Heinrich, Michael C., Marino-Enriquez, Adrian, Presnell, Ajia, Donsky, Rachel S., Griffith, Diana J., McKinley, Arin, Patterson, Janice, Taguchi, Takahiro, Liang, Cher-Wei, Fletcher, Jonathan A.
Publicat 2012

The HSP90 Inhibitor, AT13387, Is Effective against Imatinib-Sensitive and -Resistant Gastrointestinal Stromal Tumor Models

per Smyth, Tomoko, Van Looy, Thomas, Curry, Jayne E., Rodriguez-Lopez, Ana M., Wozniak, Agnieszka, Zhu, Meijun, Donsky, Rachel, Morgan, Jennifer G., Mayeda, Mark, Fletcher, Jonathan A., Schöffski, Patrick, Lyons, John, Thompson, Neil T., Wallis, Nicola G.
Publicat 2012